STAT3 and breast carcinoma: Additionally, prolonged activation of STAT3 leads to low expression of let-7 and miR-200 coupled with the upregulation of ZEB1 in OSM-triggered EMT, which contributes to the acquisition of the mesenchymal phenotype and invasive capability as well as promotion of breast cancer progression23.